News und Analysen
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Alpha Group International plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
EQS-News: German Federal Financial Supervisory Authority (BaFin) publishes increased own funds requirements for ProCredit Holding AG
EQS-News: Silver Tiger Metals: Mexico's next big silver mine?
Transaction in Own Shares
Molten Ventures Plc: Grant of Options to Persons Discharging Managerial Responsibility ('PDMR')
EQS-News: YOC AG REPORTS ACCELERATED REVENUE GROWTH IN Q2 2025 BASED ON PRELIMINARY FIGURES
Gensource Potash Announces Extension to the Maturity Date of Convertible Debentures
Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP), a fertilizer development company focused on sustainable potash production, announces an extension to the maturity date of
Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 29 March 2025 and Notice of 2025 Annual General Meeting
EQS-News: Advanced Blockchain AG starts establishing strategic BTC and ETH Reserve
Fuller, Smith & Turner PLC: Transaction in own shares
R.E.A. Holdings plc: Result of AGM
R.E.A. Holdings plc: AGM Statement
EQS-Adhoc: Medios adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50
Fuller, Smith & Turner PLC: Transaction in own shares
EQS-News: Verve Group successfully completes capital raise to broaden shareholder base, finance growth and strengthen balance sheet
Granite REIT Declares Distribution for June 2025
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2833 per unit for the month of June
Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
EQS-Adhoc: Verve Group SE: Verve successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million



